[
    [
        {
            "time": "2018-10-31",
            "original_text": "Will Walgreens (WBA) Q4 Earnings Gain From Overall Strength?",
            "features": {
                "keywords": [
                    "Walgreens",
                    "Q4 Earnings",
                    "Overall Strength"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "retail"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Will Walgreens (WBA) Q4 Earnings Gain From Overall Strength?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-11-05",
            "original_text": "US Diabetes Market Gaining Momentum: 3 Stocks in Focus",
            "features": {
                "keywords": [
                    "Diabetes Market",
                    "Gaining Momentum",
                    "Stocks in Focus"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "US Diabetes Market Gaining Momentum: 3 Stocks in Focus",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-11-06",
            "original_text": "Health-Care Stocks’ High Valuations May Not Be a Problem",
            "features": {
                "keywords": [
                    "Health-Care Stocks",
                    "High Valuations",
                    "Not a Problem"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Health-Care Stocks’ High Valuations May Not Be a Problem",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-11-07",
            "original_text": "iPhone App for Abbott's FreeStyle Libre Flash Glucose Monitoring System Makes Diabetes Management Easier and More Convenient for Canadians",
            "features": {
                "keywords": [
                    "iPhone App",
                    "Abbott",
                    "FreeStyle Libre",
                    "Diabetes Management"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "iPhone App for Abbott's FreeStyle Libre Flash Glucose Monitoring System Makes Diabetes Management Easier and More Convenient for Canadians",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]